Cassava Sciences begins extension study of Alzheimer's drug simufilam

Oct. 13, 2022 10:43 AM ETCassava Sciences, Inc. (SAVA)By: Jonathan Block, SA News Editor294 Comments

Alzheimers Concept Horizontal

travellinglight/iStock via Getty Images

Recommended For You

Comments (294)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.